Business Wire

Tech21 Announces New Collection Designed to Protect the Samsung Galaxy Note8 Drop After Drop.

Jaa

Tech21, the leader in impact protection for mobile devices, today announced a new collection of innovative cases and screen shields for the Samsung Galaxy Note8 made of unique, patented impact protection materials that guarantee the most effective drop protection on the market.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170823005888/en/

Evo Tactical for Samsung Galaxy Note8 (Photo: Business Wire)

Evo Tactical for Samsung Galaxy Note8 (Photo: Business Wire)

Tech21 products are designed to protect, drop after drop. The company does this by using scientifically proven impact materials, innovative design and a rigorous testing methodology developed in partnership with the National Physical Laboratory. Tech21 cases are drop tested 20 times to ensure durability and long lasting protection able to withstand the multiple drops that occur in the everyday use of a smartphone.

The new range includes:

Cases to match all personalities

  • Evo Check – More Than Skin Deep. There’s more to Evo Check than meets the eye. This case adds a subtle detail to the Galaxy Note8’s original beauty. But sitting beneath its unique check pattern design is an effective three-layer protection system which includes FlexShock™, an impact material unique to tech21 that provides up to 3 metres/10 feet of drop protection. Evo Check comes in Smokey/Black and Clear/White. Available at tech21.com, Smokey/Black is also available at Three, EE, O2, Very.co.uk at MSRP £34.99 Clear/White is also available at Carphone Warehouse
  • Evo Tactical – Raw, Tactile Feel. Designed to endure the busy day ahead while complimenting the Galaxy Note8’s premium design, Evo Tactical combines durable materials with refined, contrasting textures. The case comes equipped with a three-layer protection system that includes FlexShock™, and offers drop protection up to 3 metres/10 feet. The Evo Tactical case comes in black. Available at tech21.com and Carphone Warehouse at MSRP £34.99
  • Evo Wallet – Access Everything. Comfortably. With busy lifestyles we want quick and easy access to the things we use most throughout the day – our phone and our cards. The Evo Wallet features two concealed card slots in its folio cover, where cards are kept secure and easily accessible. With FlexShock™, the case also provides up to 3 metres/10 feet of drop protection. The Evo Wallet case comes in black. Available at tech21.com, Carphone Warehouse, O2 and Very.co.uk at MSRP £44.99
  • Pure Clear – Protect. Reveal. The Galaxy Note8 is beautifully designed, and a case should enhance this design. Using new materials and cutting edge technology, Pure Clear is significantly more transparent than any other clear case. Featuring BulletShield™, it’s also 50% thinner and 50% lighter than the market leader and provides up to 2 metres/6.6 feet of drop protection. Available at tech21.com, Carphone Warehouse, O2 and Very.co.uk at MSRP £34.99

Market leading screen protection

  • Impact Shield with Anti-Scratch – Advanced protection. Enduring clarity. Designed to work perfectly with the subtle curves of your screen while the strong, lasting adhesive holds it in place from edge to edge, Impact Shield Anti-Scratch has a hard, durable coating which keeps your screen smooth and crystal clear for longer than ever. It also comes equipped with BulletShield™ to absorb impact force and eliminate the fear of damaging your screen. Available at tech21.com, Carphone Warehouse, O2 and Very.co.uk at MSRP £29.99

About tech21
Since 2005, tech21 has been developing the most advanced, scientifically proven cases and screen shields for mobile, tablet and laptop devices worldwide. tech21 combines science, engineering and British design to create products that address three core consumer benefits: style, protection and performance. As the brand evolves to continue meeting the needs of its consumers, tech21 has developed the most advanced impact protection material on the market – FlexShock™. The ultra-thin and lightweight material absorbs and dissipates force and can withstand drops up to 10 feet. In addition, tech21 puts all its products through a rigorous testing program, and in an industry first has partnered with the National Physical Laboratory (NPL) to develop its testing methodology. This ensures that the tests tech21 products have to pass are overseen by independent experts. Tech21 is the number one case brand in the UK. For more information, visit tech21.com.

//

Contact information

Atomic PR on behalf of tech21
Mark Dickens
Phone: (0)20 3861 3901
Email: Tech21@atomicpr.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Brooks Levitate with DNA AMP Delivers Infinite Energy20.9.2017 07:01Tiedote

Based on seven years of Run Signature research, Brooks Running is launching the all new Levitate with DNA AMP—a shoe engineered to provide the most energy return of leading performance running shoes. The springy and responsive Brooks Levitate is available for pre-order beginning today at http://www.brooksrunning.com/en_us/brooks-levitate-running-shoes.html and will be available worldwide Sept. 30. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170919006747/en/ Brooks Levitate with DNA AMP Delivers Infinite Energy (Photo: Business Wire) “We’re pushing the limits of energy return with the new Brooks Levitate and are excited to unveil a shoe that has been engineered from the ground up to provide runners with an infinitely energetic experience,” said Carson Caprara, director of global product line ma

Ipsen Receives Approval from European Commission for Xermelo® (Telotristat Ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy19.9.2017 19:00Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced that the European Commission has approved Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. This approval allows for the marketing of Xermelo® (telotristat ethyl) in the above indication in all 28 member states of the European Union, Norway and Iceland. David Meek, Chief Executive Officer, Ipsen stated: “We are delighted to provide patients suffering from inadequately controlled carcinoid syndrome with a new treatment option in combination with a somatostatin analogue that demonstrates both efficacy and safety in particularly improving diarrhea, a most debilitating symptom. Xe

6th Annual World Patient Safety, Science & Technology Summit to Be Held in London, England19.9.2017 18:00Tiedote

The Patient Safety Movement Foundation (PSMF) announces that the 6th Annual World Patient Safety, Science & Technology Summit will take place in London on February 23-25, 2018. Rt. Hon. Jeremy Hunt MP, the Secretary of State for Health from England’s Department of Health, invited PSMF to hold its 6th annual Summit in London during his speech at the Summit in February of this year. This is the first time the Summit will be held outside of the United States. Over the years, the PSMF has taken an increasingly international scope to reach zero preventable patient deaths by 2020. They currently have over 30 Regional Chapters around the world and partnerships with global organizations such as the World Federation of Societies of Anaesthesiologists (WFSA), European Society of Anaesthesiology (ESA), Global Sepsis Alliance (GSA), the Taiwan Patient Safety Culture Club, Sistema Españo

Vertex Announces Upcoming Presentations of Data at 2017 North American Cystic Fibrosis Conference19.9.2017 17:50Tiedote

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that 11 abstracts from its cystic fibrosis (CF) research and development program will be presented at the annual North American Cystic Fibrosis Conference (NACFC) in Indianapolis, November 2 to 4, 2017. Previously announced data from the Phase 3 EVOLVE and EXPAND studies of the investigational tezacaftor/ivacaftor combination in people with CF ages 12 and older who have certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene will be presented for the first time. Additionally, data from the Phase 3 extension study of ORKAMBI® (lumacaftor/ivacaftor) in children with CF ages 6 to 11 who have two copies of the F508del mutation and real-world KALYDECO® (ivacaftor) data will be presented. The company also submitted an abstract for the late-breaking poster session with previously announced Phase 1

Biker Summer 2017 campaign: Last Chance to Win Great Prizes from Moto-tyres.co.uk19.9.2017 16:57Tiedote

Moto-tyres.co.uk wants to know: For the fifth year in a row, the online motorbike shop is asking bikers from ten European countries about their Biker Summer 2017 travel plans, favourite destinations and longest tours. For survey participants, Moto-tyres.co.uk and its sister shops in other European countries are raffling prizes to get every biker’s heart beating faster, including vouchers for new motorbike tyres, a GARMIN motorbike GPS navigation system, and a GoPro camera with helmet attachment. For more information and a link to the survey, go to: www.moto-tyres.co.uk/promotion-biker-summer-2017.html. The Biker Summer 2017 campaign is running until 30th September 2017 – so you still have time to join in and win top-quality equipment for your next bike tour. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170919006105/en/

Andersen Global Expands into Uruguay19.9.2017 16:30Tiedote

Andersen Global announces its expansion into Uruguay through a Collaboration Agreement with Fischer & Schickendantz, one of the country’s leading law firms. The addition of Fischer & Schickendantz continues Andersen Global’s expansion and robust presence within the Latin American region. The team is led by Managing Partner, Juan Federico Fischer. “The addition of Juan Federico and the individuals at Fischer & Schickendantz bring a new depth to our team and our business development efforts in South America, while allowing us to deliver additional services in the region,” said Andersen Tax CEO, Mark Vorsatz. “Uruguay is the next major step in our firm’s growth and is an excellent complement for Andersen Global. The ability to provide a full scope of services in Uruguay offers significant advantages, especially given their large cross border client base and Uruguay’s increase

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme